WW International, Inc. (WW)
NASDAQ: WW · Real-Time Price · USD
0.3956
+0.2480 (168.02%)
At close: Apr 25, 2025, 4:00 PM
0.4000
+0.0044 (1.11%)
After-hours: Apr 25, 2025, 7:59 PM EDT

Company Description

WW International, Inc. provides weight management products and services in the United States, Germany, and internationally.

It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes.

The company also provides various digital subscription products to weight loss and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and web-based platform, as well as allows members to inspire and support each other by sharing their experiences with other people on weight health journeys.

In addition, it licenses its trademarks and other intellectual property in food, beverages, and other weight management-relevant consumer products and services, as well as provides publishing services.

The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019.

WW International, Inc. was founded in 1963 and is headquartered in New York, New York.

WW International, Inc.
WW International logo
Country United States
Founded 1961
IPO Date Nov 15, 2001
Industry Personal Services
Sector Consumer Discretionary
Employees 3,700
CEO Tara Comonte

Contact Details

Address:
675 Avenue of the Americas, 6th Floor
New York, New York 10010
United States
Phone 212 589 2700
Website corporate.ww.com

Stock Details

Ticker Symbol WW
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000105319
CUSIP Number 98262P101
ISIN Number US98262P1012
Employer ID 11-6040273
SIC Code 7200

Key Executives

Name Position
Tara M. Comonte President, Chief Executive Officer and Director
Felicia DellaFortuna Chief Financial Officer
Nicole Haag Corporate Controller and Principal Accounting Officer
Jacqueline Cooke Chief Legal and Administrative Officer and Secretary
David Helderman Director of Investor Relations
Michael Amsel Chief Marketing Officer
Tony Yen Head of Taiwan
Donna Boyer Chief Product Officer
Phillip Picardi Chief Impact Officer
Scott Honken PharmD Chief Commercial Officer

Latest SEC Filings

Date Type Title
Apr 25, 2025 SCHEDULE 13D Filing
Apr 21, 2025 ARS Filing
Apr 21, 2025 DEF 14A Other definitive proxy statements
Mar 21, 2025 8-K Current Report
Feb 28, 2025 10-K Annual Report
Feb 27, 2025 8-K Current Report
Feb 3, 2025 8-K Current Report
Nov 27, 2024 8-K Current Report
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 8, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals